Impact of LDL-cholesterol Lowering on Platelet Activation

NCT03331666 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Terminated Prematurely due to COVID-19

Conditions

Familial Hypercholesterolemia

Interventions

DRUG: Evolocumab

Sponsor

Columbia University

Collaborators

[object Object]